Figure 2From: Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinomaA combined analysis of the preoperative serum CA19-9 level, R0 resection, and number of lymph node metastases being two or less. The subgroup of preoperative serum CA19-9 ≤ 40 U/mL and R0 resection, together with number of lymph node metastases ≤2, is associated with a probability of five-year survival of 42.1%. MST, median survival time.Back to article page